一种新型局部抗组胺药（左卡巴斯汀）的多中心评估
[Multicenter evaluation of a new local antihistaminic drug (levocabastine)].
作者信息
Bischoff P, Gerber M
机构信息
Klinik für Augenkrankheiten, Kantonsspital St. Gallen.
出版信息
Klin Monbl Augenheilkd. 1992 May;200(5):354-7. doi: 10.1055/s-2008-1045764.
The aim of this prospective, open study was to evaluate the efficacy and tolerance of the Levocabastine eye drops in daily practice. 273 patients with allergic (rhino)conjunctivitis were treated during 2 weeks. Objective findings and subjective assessments made by the patients were analyzed. The global efficacy was evaluated by the investigator as good or excellent in 73.8% (eye) and 53.6% (nose) of the patients. The results were not age-dependent. The tolerance was scored as good or excellent in 89% of the patients. Less than 6% of the patients stopped the treatment due to intolerance.
这项前瞻性开放性研究的目的是评估左卡巴斯汀滴眼液在日常实践中的疗效和耐受性。273例过敏性（鼻）结膜炎患者接受了为期2周的治疗。对患者的客观检查结果和主观评估进行了分析。研究者评估总体疗效为良好或优秀的患者，眼部占73.8%，鼻部占53.6%。结果与年龄无关。89%的患者耐受性评分良好或优秀。因不耐受而停止治疗的患者不到6%。
Zotero 插件